Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Sickle Cell Disease and Sickle Cell Disease

View overview page
5:16
Disease-modifying and curative SCD treatment updates from ASCAT 2023
Subarna Chakravorty • 26 Oct 2023
3:03
ASCAT 2023: goals and current projects
Baba Inusa • 27 Oct 2023
3:29
Antithrombotic effects of isoquercetin in sickle cell disease
Bindu Parachalil Gopalan • 30 Jun 2023
1:21
The importance of providing high-quality care to adult patients with SCD
Rabi Hanna • 11 Jun 2023
1:04
SCD highlights from EHA 2023: the biology of pain crises & Solace-kids
Rabi Hanna • 11 Jun 2023
2:07
Phase I/II study of EDIT-301, a novel gene-edited autologous HSC medicine, in patients with SCD
Rabi Hanna • 11 Jun 2023
8:19
CLIMB Thal-111 & CLIMB SCD-121: TI and elimination of VOCs after exa-cel in TDT and SCD
Franco Locatelli • 9 Jun 2023
1:52
Exploring the possibility of treating SCD in-utero with novel gene-editing technology
Panicos Shangaris • 24 Apr 2023
1:02
Evaluating the correlation between sleep and QoL in patients with sickle cell disease
Sanne Lugthart • 24 Apr 2023
3:04
Session highlights: top abstracts in red cell disorders
Subarna Chakravorty • 24 Apr 2023
2:46
Optimizing care and improving quality of life in pediatric patients with sickle cell disease
Subarna Chakravorty • 24 Apr 2023
1:36
The limitations and future of precision medicine in sickle cell disease
Sara El Hoss • 23 Apr 2023
1:11
Precision medicine in sickle cell disease: current status and future outlooks
Sara El Hoss • 24 Apr 2023
1:59
Prospective study evaluating complement activation in patients with sickle cell disease
Eleni Gavriilaki • 12 Dec 2022
0:54
Long-term effects of haploidentical transplantation on pulmonary function in patients with SCD
Courtney Fitzhugh • 10 Dec 2022
2:44
Pentostatin + cyclophosphamide for patients with SCD undergoing haploidentical transplantation
Courtney Fitzhugh • 10 Dec 2022

The Sickle Cell Disease Channel on VJHemOnc is supported by Agios Pharmaceuticals

The supporter has no influence over the production of the content.

If you are interested in becoming a supporter of The Non-Malignant Channel, please contact us.

The content of VJHemOnc is intended for healthcare professionals